BNGO (STOCKS)
Bionano Genomics, Inc. Common Stock
$1.152900
+0.022900 (+2.03%)
Prev close: $1.130000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Robert Erik Holmlin
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $13.03M
- Employees
- 100
- P/E (TTM)
- -0.22
- P/B (TTM)
- 0.27
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.03 | $-1.43 | +1.3980 | +97.90% |
|
Sep 2025 (Q3)
|
$-1.59 | $-1.95 | +0.3582 | +18.39% |
|
Jun 2025 (Q2)
|
$-1.99 | $-2.46 | +0.4733 | +19.21% |
|
Mar 2025 (Q1)
|
$-1.15 | $-3.08 | +1.9328 | +62.68% |
Financial Statements
| Revenues | $28.51M |
| Benefits Costs and Expenses | $54.84M |
| Cost Of Revenue | $15.32M |
| Costs And Expenses | $46.52M |
| Gross Profit | $13.19M |
| Nonoperating Income/Loss | $7.01M |
| Operating Expenses | $46.52M |
| Selling, General, and Administrative Expenses | $35.15M |
| Research and Development | $11.37M |
| Operating Income/Loss | -$33.34M |
| Income/Loss From Continuing Operations After Tax | -$26.40M |
| Income/Loss From Continuing Operations Before Tax | -$26.33M |
| Income Tax Expense/Benefit | $67.00K |
| Income Tax Expense/Benefit, Current | $67.00K |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$26.40M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$26.40M |
| Net Income/Loss Available To Common Stockholders, Basic | -$26.40M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$4.85 |
| Diluted Earnings Per Share | -$4.85 |
| Basic Average Shares | 5,445,000 |
| Diluted Average Shares | 5,445,000 |
| Assets | $73.58M |
| Current Assets | $45.39M |
| Inventory | $7.83M |
| Other Current Assets | $37.56M |
| Noncurrent Assets | $28.20M |
| Fixed Assets | $14.85M |
| Intangible Assets | $4.35M |
| Other Non-current Assets | $9.01M |
| Liabilities | $29.16M |
| Current Liabilities | $22.94M |
| Accounts Payable | $5.59M |
| Wages | $3.54M |
| Other Current Liabilities | $13.82M |
| Noncurrent Liabilities | $6.22M |
| Equity | $44.42M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $44.42M |
| Liabilities And Equity | $73.58M |
| Net Cash Flow From Operating Activities | -$16.35M |
| Net Cash Flow From Operating Activities, Continuing | -$16.35M |
| Net Cash Flow From Investing Activities | -$12.75M |
| Net Cash Flow From Investing Activities, Continuing | -$12.75M |
| Net Cash Flow From Financing Activities | $24.04M |
| Net Cash Flow From Financing Activities, Continuing | $24.04M |
| Exchange Gains/Losses | -$11.00K |
| Net Cash Flow | -$5.06M |
| Net Cash Flow, Continuing | -$5.05M |
| Comprehensive Income/Loss | -$26.41M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$26.41M |
| Other Comprehensive Income/Loss | -$26.41M |
| Other Comprehensive Income/Loss Attributable To Parent | -$10.00K |